| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| dalazatide | voltage-gated potassium channel kv1.3 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Inclusion Body Myositis (disorder)[MeSHID:D018979] Dental Plaque[MeSHID:D003773] Psoriasis[MeSHID:D011565] Senile Plaques[MeSHID:D058225] |
10.61 | phase 1b/2a | unknown |
| click here to return to the previous page | ||||||||